Clinical Approach to Fatigue
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of fatigue
Fatigue is one of the most common presenting complaints in primary care, accounting for approximately 5-10% of all physician visits. Studies indicate that up to 45% of the general population experiences significant fatigue at any given time, with 20-30% reporting persistent fatigue lasting more than one month. Despite its prevalence, fatigue remains one of the most diagnostically challenging symptoms, with an identifiable organic cause found in only 50-60% of cases after initial evaluation.
Definition
Fatigue is a subjective sensation of overwhelming, sustained exhaustion and decreased capacity for physical and mental work that is not relieved by rest. It represents a disruption in the body’s normal homeostatic mechanisms for energy production, utilization, or recovery, and should be distinguished from sleepiness, weakness, and dyspnea on exertion.
Critical Distinctions
| Term | Definition | Key Feature | Suggests |
|---|---|---|---|
| Fatigue | Lack of energy, exhaustion, tiredness | Not relieved by rest | Systemic illness, psychiatric, chronic disease |
| Sleepiness | Tendency to fall asleep | Relieved by sleep | Sleep disorders, sedating medications |
| Weakness | Reduced muscle strength | Objective motor deficit | Neuromuscular disease, myopathy |
| Exercise intolerance | Inability to perform physical activity | Dyspnea, chest pain with exertion | Cardiopulmonary disease |
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Less than 1 month | Acute infection, medication effect, acute stress, sleep deprivation | Often self-limited; evaluate for acute illness |
| Subacute | 1 to 6 months | Post-viral syndrome, undiagnosed anemia, thyroid dysfunction, depression | Warrants systematic investigation; may resolve or progress |
| Chronic | Greater than 6 months | Chronic disease, psychiatric disorders, myalgic encephalomyelitis/chronic fatigue syndrome | Requires comprehensive evaluation; significant impact on quality of life |
Classification by Character
Physical Fatigue
Description: Predominant inability to sustain physical activity; muscles feel heavy or weak; requires rest after minimal exertion.
Suggests: Anemia, cardiopulmonary disease, neuromuscular disorders, endocrine dysfunction, chronic infection
Mental Fatigue
Description: Difficulty concentrating, cognitive slowing, poor memory, reduced motivation; “brain fog”
Suggests: Depression, anxiety, sleep disorders, hypothyroidism, vitamin B12 deficiency, early dementia
Classification by Pattern and Timing
| Pattern | Description | Suggests |
|---|---|---|
| Morning predominant | Worst upon waking, improves through day | Depression, sleep disorders, adrenal insufficiency |
| Afternoon predominant | Develops or worsens as day progresses | Chronic disease burden, anemia, sleep deprivation |
| Post-exertional | Worsens disproportionately after activity, delayed recovery | Myalgic encephalomyelitis/chronic fatigue syndrome, heart failure, mitochondrial disorders |
| Constant | Unremitting throughout the day | Malignancy, chronic infection, severe depression |
| Intermittent | Episodic with symptom-free intervals | Multiple sclerosis, periodic syndromes, cyclic mood disorders |
Key Epidemiological Facts
- Prevalence: 20-30% of adults report persistent fatigue; higher in women (1.5:1 ratio)
- Primary care burden: 5-10% of all consultations; top 10 reason for visits
- Organic cause identified: 50-60% after initial workup; 5-10% have serious underlying disease
- Psychiatric contribution: Depression and anxiety account for 40-50% of chronic fatigue cases
- Quality of life impact: Comparable to that of chronic conditions like heart disease and arthritis
Key Concept — The “Big Five” Causes: In primary care, five categories account for the majority of identifiable fatigue causes: psychiatric disorders (depression, anxiety), sleep disorders (obstructive sleep apnea, insomnia), endocrine dysfunction (thyroid disease, diabetes), hematologic abnormalities (anemia), and medications/substances. A systematic approach targeting these categories first yields the highest diagnostic return.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of fatigue
Fatigue results from disruption at any level of the complex physiological systems governing energy production, utilization, and perception. Unlike simpler symptoms with discrete pathways, fatigue represents the final common manifestation of diverse pathological processes affecting cellular metabolism, neurotransmission, hormonal regulation, and immune function. Understanding these mechanisms guides rational investigation and targeted treatment.
The Energy Production Pathway
| Level | Component | Function | Disruption Causes |
|---|---|---|---|
| Substrate delivery | Oxygen, glucose, nutrients | Provide raw materials for ATP synthesis | Anemia, hypoxia, malnutrition, malabsorption |
| Cellular uptake | Transport proteins, insulin signaling | Move substrates into cells | Diabetes mellitus, insulin resistance |
| Mitochondrial function | Electron transport chain, oxidative phosphorylation | Generate ATP from substrates | Mitochondrial disorders, coenzyme Q10 deficiency, chronic inflammation |
| ATP utilization | Muscle contraction, neural transmission | Convert chemical energy to work | Myopathies, channelopathies, electrolyte disturbances |
| Waste removal | Carbon dioxide, lactate clearance | Maintain cellular homeostasis | Cardiopulmonary disease, hepatic dysfunction |
Categories of Fatigue Mechanisms
Peripheral Fatigue
Location: Muscles, neuromuscular junction
Mechanism: Failure of muscle fiber activation or contraction despite adequate central drive
Clinical relevance: Objective weakness on examination; responds to rest; seen in myopathies, electrolyte disorders, neuromuscular junction diseases
Central Fatigue
Location: Central nervous system
Mechanism: Reduced voluntary activation of muscles due to altered neurotransmitter function (serotonin, dopamine, norepinephrine)
Clinical relevance: Subjective exhaustion exceeds objective findings; prominent in depression, multiple sclerosis, myalgic encephalomyelitis/chronic fatigue syndrome
Metabolic Fatigue
Location: Cellular/systemic
Mechanism: Insufficient substrate delivery or ATP production; accumulation of metabolic byproducts
Clinical relevance: Prominent exertional component; seen in anemia, cardiopulmonary disease, endocrine disorders, malnutrition
How Conditions Cause Fatigue
| Condition | Primary Mechanism | Treatment Implication |
|---|---|---|
| Anemia | Reduced oxygen-carrying capacity leads to tissue hypoxia and impaired oxidative metabolism; compensatory tachycardia increases cardiac workload | Identify and treat underlying cause; iron/B12/folate replacement; transfusion if severe |
| Hypothyroidism | Thyroid hormone deficiency reduces basal metabolic rate and mitochondrial function; decreases beta-adrenergic responsiveness | Levothyroxine replacement with gradual dose titration |
| Diabetes mellitus | Impaired glucose uptake despite hyperglycemia; osmotic diuresis causes dehydration; microvascular complications affect tissue perfusion | Glycemic control; address complications; screen for comorbidities |
| Depression | Dysregulation of serotonin, norepinephrine, and dopamine reduces central drive and reward processing; HPA axis hyperactivity | Antidepressants targeting specific neurotransmitter deficits; psychotherapy; exercise |
| Obstructive sleep apnea | Repetitive hypoxemia and sleep fragmentation prevent restorative sleep stages; sympathetic activation; systemic inflammation | Continuous positive airway pressure therapy; weight loss; positional therapy |
| Heart failure | Reduced cardiac output limits oxygen delivery; skeletal muscle atrophy; neurohormonal activation (elevated cytokines) | Guideline-directed medical therapy; cardiac rehabilitation; diuretics for congestion |
| Chronic kidney disease | Uremic toxin accumulation; anemia from reduced erythropoietin; metabolic acidosis; secondary hyperparathyroidism | Treat anemia with erythropoiesis-stimulating agents; correct acidosis; phosphate management |
| Malignancy | Tumor-derived cytokines (interleukin-1, interleukin-6, tumor necrosis factor-alpha); anemia; metabolic derangements; treatment effects | Treat underlying malignancy; exercise programs; address anemia and nutritional deficits |
| Myalgic encephalomyelitis/chronic fatigue syndrome | Incompletely understood; involves immune dysregulation, autonomic dysfunction, and abnormal central processing of exertion signals | Activity pacing; address comorbidities; avoid graded exercise that triggers post-exertional malaise |
The Role of Inflammation
Cytokine-Induced Fatigue: Pro-inflammatory cytokines (interleukin-1, interleukin-6, tumor necrosis factor-alpha, interferon-gamma) directly affect the central nervous system, producing “sickness behavior” characterized by fatigue, anorexia, social withdrawal, and cognitive impairment. This represents an adaptive response to infection but becomes maladaptive in chronic inflammatory states.
- Acute infection: Rapid cytokine release produces acute fatigue as part of sickness behavior
- Chronic inflammation: Persistent low-grade elevation seen in autoimmune disease, obesity, heart failure, and malignancy
- Post-viral fatigue: Prolonged immune activation and cytokine dysregulation may persist weeks to months after acute infection
Hypothalamic-Pituitary-Adrenal Axis Dysregulation
| State | HPA Axis Pattern | Associated Conditions | Clinical Features |
|---|---|---|---|
| Hyperactivation | Elevated cortisol, loss of diurnal variation | Major depression, chronic stress, Cushing syndrome | Fatigue with insomnia, weight gain, mood disturbance |
| Hypoactivation | Blunted cortisol response, low morning cortisol | Adrenal insufficiency, burnout, myalgic encephalomyelitis/chronic fatigue syndrome | Profound fatigue, salt craving, orthostatic symptoms |
| Dysregulation | Abnormal diurnal rhythm, variable responses | Post-traumatic stress disorder, fibromyalgia, chronic pain | Fatigue with pain, hypervigilance, sleep disturbance |
Often Overlooked Mechanism
Medication-induced mitochondrial dysfunction: Many common medications impair mitochondrial function and can cause or worsen fatigue. Statins inhibit coenzyme Q10 synthesis. Metformin depletes vitamin B12 and may affect mitochondrial complex I. Beta-blockers reduce exercise capacity by limiting heart rate response. Antihistamines, benzodiazepines, and many psychotropic medications cause central sedation. Always perform a thorough medication review in any patient presenting with fatigue — the offending agent may be one that has been used for years without prior issues.
Neurotransmitter Contributions to Central Fatigue
| Neurotransmitter | Normal Role in Energy/Alertness | Effect of Deficiency | Relevant Conditions |
|---|---|---|---|
| Dopamine | Motivation, reward, motor initiation | Apathy, amotivation, psychomotor slowing | Parkinson disease, depression, chronic stress |
| Norepinephrine | Alertness, attention, energy mobilization | Fatigue, poor concentration, cognitive slowing | Depression, attention deficit disorders |
| Serotonin | Mood regulation, sleep-wake cycles | Fatigue associated with low mood, sleep disruption | Depression, anxiety, fibromyalgia |
| Histamine | Wakefulness, arousal | Excessive sleepiness, reduced alertness | Antihistamine use, narcolepsy |
| Orexin/Hypocretin | Wakefulness maintenance, energy homeostasis | Excessive daytime sleepiness, cataplexy | Narcolepsy type 1 |
3. History Taking
A comprehensive approach to eliciting the fatigue history
Red Flags — Require Urgent Evaluation
- Unintentional weight loss greater than 5% — Malignancy, hyperthyroidism, adrenal insufficiency
- Fever or night sweats — Infection, malignancy, autoimmune disease
- Lymphadenopathy — Lymphoma, leukemia, metastatic cancer, infection
- Severe dyspnea or chest pain — Heart failure, pulmonary embolism, coronary artery disease
- New focal neurological deficits — Stroke, multiple sclerosis, brain tumor
- Suicidal ideation — Severe depression requiring urgent psychiatric evaluation
- Severe pallor or bleeding — Severe anemia, hematologic malignancy
- Signs of adrenal crisis — Hypotension, hyperpigmentation, salt craving, abdominal pain
Systematic History: The “TIRED” Approach
Use the mnemonic “TIRED” to ensure comprehensive history taking:
- T — Timeline and Trajectory: When did it start? Sudden or gradual? Getting better, worse, or stable? Constant or intermittent? Any symptom-free periods?
- I — Impact and Interference: How does it affect work, relationships, daily activities? Can you exercise? How has your life changed? What can’t you do anymore?
- R — Rest and Recovery: Does sleep help? How many hours do you sleep? Do you feel refreshed upon waking? What makes it better or worse? Does activity worsen fatigue disproportionately?
- E — Emotional and Mental State: How is your mood? Interest in activities? Concentration? Anxiety or worry? Stress at home or work? Any feelings of hopelessness?
- D — Drugs, Diet, and Disease: Current medications (including over-the-counter and supplements)? Alcohol, caffeine, recreational drugs? Eating habits? Known medical conditions? Recent infections?
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Depression | Low mood, anhedonia, guilt, poor concentration, sleep changes | “Over the past two weeks, have you felt down, depressed, or hopeless? Have you lost interest in things you used to enjoy?” |
| Anxiety disorder | Excessive worry, restlessness, muscle tension, poor sleep | “Do you find yourself worrying excessively about different things? Do you feel on edge or have trouble relaxing?” |
| Obstructive sleep apnea | Snoring, witnessed apneas, morning headaches, unrefreshing sleep | “Has anyone ever told you that you snore loudly or stop breathing during sleep? Do you wake up with headaches or a dry mouth?” |
| Hypothyroidism | Cold intolerance, weight gain, constipation, dry skin, bradycardia | “Have you noticed feeling colder than others, unexplained weight gain, or changes in your skin or hair?” |
| Anemia | Exertional dyspnea, palpitations, pallor, heavy menses, dietary deficiency | “Do you get short of breath or notice your heart racing with activities that didn’t bother you before? Are your periods heavy?” |
| Diabetes mellitus | Polyuria, polydipsia, weight change, blurred vision, infections | “Have you been urinating more frequently, especially at night? Have you been unusually thirsty?” |
| Heart failure | Exertional dyspnea, orthopnea, leg swelling, paroxysmal nocturnal dyspnea | “Do you get short of breath when you exert yourself or lie flat? Have you noticed swelling in your ankles?” |
| Chronic infection | Fever, night sweats, weight loss, risk factors for tuberculosis or HIV | “Have you had fevers, night sweats that soak your clothes, or unexplained weight loss? Any recent travel or high-risk exposures?” |
| Malignancy | Weight loss, night sweats, new masses, bleeding, pain | “Have you noticed any lumps, unexplained bleeding, or persistent pain? Have you lost weight without trying?” |
| Adrenal insufficiency | Salt craving, hyperpigmentation, orthostatic symptoms, nausea | “Do you crave salty foods? Do you feel dizzy when you stand up? Has anyone noticed your skin getting darker?” |
| Myalgic encephalomyelitis/chronic fatigue syndrome | Post-exertional malaise, unrefreshing sleep, cognitive dysfunction, orthostatic intolerance | “Does physical or mental activity make your fatigue significantly worse for days afterward? Do you feel worse, not better, after exercise?” |
Comprehensive Sleep History
Essential Sleep Questions
Sleep disorders are among the most common and treatable causes of fatigue. Take a thorough sleep history:
- Duration: What time do you go to bed and wake up? How many hours of sleep do you get?
- Quality: Do you feel refreshed when you wake up? How would you rate your sleep quality?
- Latency: How long does it take you to fall asleep?
- Fragmentation: Do you wake up during the night? How often? Why?
- Snoring/Apnea: Do you snore? Has anyone witnessed you stop breathing?
- Movements: Do you or your partner notice leg movements or restlessness?
- Daytime sleepiness: Do you fall asleep during the day unintentionally? (Use Epworth Sleepiness Scale)
- Sleep hygiene: Screen time before bed? Caffeine intake? Bedroom environment?
Medication and Substance History
Medications That Commonly Cause Fatigue
- Beta-blockers — Reduce exercise capacity, cause central fatigue
- Antihistamines — Central sedation, especially first-generation
- Benzodiazepines and sedative-hypnotics — Residual daytime sedation
- Opioids — Central nervous system depression, hypogonadism
- Antidepressants — Especially tricyclics and mirtazapine
- Antipsychotics — Sedation, metabolic effects
- Anticonvulsants — Central nervous system depression
- Statins — Myopathy, coenzyme Q10 depletion
- Proton pump inhibitors — Vitamin B12, magnesium deficiency (long-term)
- Diuretics — Electrolyte disturbances, dehydration
- Antihypertensives — Especially centrally acting agents
- Chemotherapy agents — Direct and indirect effects
Substance Use and Lifestyle Factors
- Alcohol: Sleep fragmentation, liver disease, nutritional deficiency, depression
- Caffeine: Paradoxical fatigue from withdrawal or sleep disruption
- Cannabis: Amotivational syndrome, sleep architecture disruption
- Stimulants: Crash phenomenon, sleep deprivation
- Nicotine: Sleep disruption, cardiovascular effects
Dietary Considerations
- Restrictive diets: Risk of iron, B12, folate deficiency
- Vegetarian/vegan: B12, iron, zinc deficiency
- Eating disorders: Malnutrition, electrolyte disturbances
- Excessive sugar intake: Reactive hypoglycemia
Social and Occupational History
| Domain | Key Questions | Relevance |
|---|---|---|
| Work | Type of work? Hours? Shift work? Job satisfaction? Recent changes? | Shift work disrupts circadian rhythm; burnout is common; occupational exposures |
| Relationships | Marital status? Caregiver responsibilities? Social support? | Caregiver fatigue; relationship stress; social isolation worsens depression |
| Life stressors | Recent losses? Financial stress? Major life changes? | Psychosocial stress is a major contributor to fatigue |
| Exercise | Current activity level? Previous activity? Barriers? | Deconditioning worsens fatigue; exercise is therapeutic for many causes |
| Screen time | Hours per day? Evening use? Social media impact? | Disrupts sleep; associated with depression and anxiety |
Validated Screening Tools
Consider using standardized instruments to quantify symptoms and screen for common causes:
- PHQ-9: Depression screening — score ≥10 suggests moderate depression
- GAD-7: Anxiety screening — score ≥10 suggests moderate anxiety
- Epworth Sleepiness Scale: Daytime sleepiness — score >10 indicates excessive sleepiness
- STOP-BANG: Obstructive sleep apnea risk — score ≥3 indicates intermediate to high risk
- Fatigue Severity Scale: Quantifies fatigue impact — useful for monitoring
4. Physical Examination
A systematic head-to-toe approach for fatigue
Systematic Framework: Use the “General to Specific” approach for complete examination of patients presenting with fatigue. Begin with general observation and vital signs, then proceed systematically through each organ system looking for clues to underlying etiology.
General Inspection
- Appearance: Well or unwell? Cachexic or obese? Apparent age versus stated age? Grooming and hygiene (may indicate depression or cognitive impairment)?
- Affect and behavior: Flat affect, psychomotor retardation (depression)? Anxious, restless (anxiety)? Apathetic (frontal lobe dysfunction)?
- Body habitus: Obesity (sleep apnea, metabolic syndrome), weight loss (malignancy, hyperthyroidism, malnutrition), cushingoid features
- Skin color: Pallor (anemia), jaundice (liver disease), hyperpigmentation (adrenal insufficiency), gray (hemochromatosis)
- Speech and cognition: Slow, monotonous speech (hypothyroidism, depression)? Word-finding difficulty? Concentration problems?
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Temperature | Fever or hypothermia | Fever suggests infection or malignancy; hypothermia may indicate hypothyroidism or sepsis |
| Heart rate | Tachycardia or bradycardia | Tachycardia: anemia, hyperthyroidism, heart failure, anxiety. Bradycardia: hypothyroidism, beta-blocker effect, heart block |
| Blood pressure | Hypertension or hypotension | Hypotension: adrenal insufficiency, dehydration, autonomic dysfunction. Hypertension: consider secondary causes |
| Orthostatic vitals | Drop in systolic blood pressure ≥20 mmHg or heart rate rise ≥30 bpm on standing | Suggests dehydration, autonomic dysfunction, adrenal insufficiency, medication effect, or postural orthostatic tachycardia syndrome |
| Respiratory rate | Tachypnea at rest | Cardiopulmonary disease, anemia, metabolic acidosis |
| Oxygen saturation | Hypoxemia at rest or with ambulation | Pulmonary disease, heart failure, pulmonary hypertension, anemia |
| Weight and body mass index | Recent weight change; body mass index >30 or <18.5 | Weight loss: malignancy, hyperthyroidism, malabsorption. Weight gain: hypothyroidism, depression. Obesity: sleep apnea risk |
Head, Eyes, Ears, Nose, and Throat Examination
Eyes
- Conjunctival pallor: Anemia
- Scleral icterus: Hemolysis, liver disease
- Lid lag, proptosis: Hyperthyroidism (Graves disease)
- Periorbital edema: Hypothyroidism, nephrotic syndrome
- Dry eyes: Sjögren syndrome
Mouth and Throat
- Glossitis: Iron, B12, or folate deficiency
- Angular cheilitis: Iron deficiency, B vitamin deficiency
- Dry mouth: Sjögren syndrome, medication effect
- Oropharyngeal crowding: Obstructive sleep apnea risk
- Oral candidiasis: Immunosuppression, diabetes
Neck Examination
- Thyroid: Goiter (hyper- or hypothyroidism), nodules (thyroid cancer), tenderness (thyroiditis)
- Lymphadenopathy: Location, size, consistency, mobility — suggests infection, lymphoma, metastatic disease
- Jugular venous pressure: Elevated in heart failure, pericardial disease, pulmonary hypertension
- Neck circumference: Greater than 17 inches in men or 16 inches in women increases sleep apnea risk
Cardiovascular Examination
| Finding | Description | Conditions |
|---|---|---|
| Displaced apex beat | Lateral and/or inferior displacement | Left ventricular dilation (cardiomyopathy, heart failure) |
| Third heart sound (S3) | Low-frequency sound in early diastole | Heart failure with reduced ejection fraction, volume overload |
| Fourth heart sound (S4) | Presystolic sound indicating stiff ventricle | Hypertensive heart disease, ischemia, hypertrophic cardiomyopathy |
| Murmurs | Systolic or diastolic abnormal sounds | Valvular heart disease; flow murmurs may indicate anemia |
| Peripheral edema | Bilateral pitting edema of lower extremities | Heart failure, venous insufficiency, nephrotic syndrome, liver disease |
| Weak peripheral pulses | Diminished or absent pulses | Peripheral vascular disease, low cardiac output |
Respiratory Examination
Inspection
- Barrel chest (chronic obstructive pulmonary disease)
- Use of accessory muscles, pursed-lip breathing
- Kyphoscoliosis (restrictive lung disease)
Percussion and Auscultation
| Finding | Description | Conditions |
|---|---|---|
| Dullness to percussion | Decreased resonance over lung fields | Pleural effusion, consolidation, mass |
| Crackles (rales) | Discontinuous sounds, fine or coarse | Pulmonary edema (heart failure), interstitial lung disease, pneumonia |
| Wheezes | Continuous musical sounds | Asthma, chronic obstructive pulmonary disease, cardiac asthma |
| Decreased breath sounds | Reduced air entry | Pleural effusion, pneumothorax, severe chronic obstructive pulmonary disease |
Abdominal Examination
- Hepatomegaly: Liver disease, heart failure, malignancy, infection
- Splenomegaly: Hematologic malignancy, infection, portal hypertension, hemolysis
- Ascites: Liver cirrhosis, heart failure, malignancy, nephrotic syndrome
- Masses: Malignancy, lymphadenopathy
- Tenderness: Consider infectious or inflammatory causes
Skin Examination
| Finding | Description | Conditions |
|---|---|---|
| Pallor | Pale skin and mucous membranes | Anemia of any cause |
| Hyperpigmentation | Diffuse darkening, especially creases, scars, gums | Primary adrenal insufficiency (Addison disease) |
| Dry, coarse skin | Thick, rough skin texture with delayed relaxation after pinching | Hypothyroidism |
| Warm, moist skin | Warm to touch with increased sweating | Hyperthyroidism |
| Jaundice | Yellow discoloration of skin and sclerae | Liver disease, hemolysis |
| Petechiae/purpura | Non-blanching spots or patches | Thrombocytopenia, vasculitis, coagulopathy |
| Rashes | Various morphologies | Autoimmune disease (lupus butterfly rash, dermatomyositis) |
Neurological Examination
- Mental status: Cognitive screening (consider Mini-Mental State Examination or Montreal Cognitive Assessment if concern for cognitive impairment)
- Cranial nerves: Papilledema (intracranial pathology), facial weakness
- Motor examination: True weakness versus fatigue-related give-way weakness; proximal weakness suggests myopathy
- Reflexes: Delayed relaxation phase (hypothyroidism), hyperreflexia (hyperthyroidism, upper motor neuron lesion)
- Sensory examination: Peripheral neuropathy (diabetes, B12 deficiency)
- Coordination and gait: Ataxia, broad-based gait (B12 deficiency, cerebellar pathology)
Musculoskeletal Examination
- Muscle bulk: Wasting suggests myopathy, disuse, malignancy, chronic disease
- Muscle tenderness: Myositis, fibromyalgia tender points
- Proximal weakness: Difficulty rising from chair, climbing stairs — suggests myopathy, thyroid disease, Cushing syndrome
- Joint examination: Synovitis, deformity — inflammatory arthritis, autoimmune disease
Expected Findings by Etiology
| Condition | General Appearance | Key Physical Findings | Often Normal? |
|---|---|---|---|
| Depression | Poor grooming, flat affect, psychomotor retardation | May have none; reduced eye contact, slow speech | Yes — often normal examination |
| Obstructive sleep apnea | Often obese, sleepy appearance | Obesity, large neck circumference, oropharyngeal crowding, hypertension | Sometimes — may have no findings in mild cases |
| Hypothyroidism | Puffy face, slow movements, hoarse voice | Bradycardia, goiter, delayed reflex relaxation, dry skin, periorbital edema | Sometimes — early or mild cases may be normal |
| Anemia | Pallor | Conjunctival pallor, tachycardia, flow murmur, koilonychia (iron deficiency) | Sometimes — mild anemia may show no findings |
| Heart failure | May appear dyspneic, fatigued | Elevated jugular venous pressure, S3, displaced apex, peripheral edema, pulmonary crackles | No — usually has findings in symptomatic disease |
| Malignancy | Cachexia, pallor | Weight loss, lymphadenopathy, hepatosplenomegaly, masses | Sometimes — early disease may be normal |
| Adrenal insufficiency | Appears unwell, hyperpigmented | Hyperpigmentation (creases, scars, gums), hypotension, orthostatic changes | Sometimes — may be subtle |
| Myalgic encephalomyelitis/chronic fatigue syndrome | May appear normal or tired | Usually normal examination; may have tender lymph nodes, low-grade fever | Yes — characteristically normal examination |
Important Teaching Point
Normal examination is common! Many of the most frequent causes of fatigue — including depression, anxiety, early hypothyroidism, mild anemia, medication effects, sleep disorders, and myalgic encephalomyelitis/chronic fatigue syndrome — often present with entirely normal physical examination findings. A normal examination does not exclude significant pathology and should prompt thorough history taking and targeted investigations rather than reassurance alone.
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
Acute Fatigue (Duration: Less than 1 month)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 70%) | Acute viral infection | Fever, myalgias, upper respiratory symptoms, recent sick contacts | High fever, severe dyspnea, altered mental status |
| Sleep deprivation | Clear history of inadequate sleep, lifestyle factors, new baby, shift work | None specific | |
| Acute stress or adjustment disorder | Identifiable stressor, anxiety, difficulty coping, recent life change | Suicidal ideation, inability to function | |
| Medication effect (new or changed) | Temporal relationship to medication initiation or dose change | Signs of toxicity or overdose | |
| LESS COMMON (approximately 20%) | Infectious mononucleosis | Adolescent or young adult, pharyngitis, lymphadenopathy, splenomegaly | Airway compromise, splenic rupture risk |
| Acute anemia (bleeding) | Pallor, tachycardia, known bleeding source, melena, heavy menses | Hemodynamic instability, ongoing blood loss | |
| New-onset diabetes mellitus | Polyuria, polydipsia, weight loss, blurred vision | Diabetic ketoacidosis features | |
| UNCOMMON BUT SERIOUS (approximately 10%) | Acute myocardial infarction | Chest discomfort, dyspnea, diaphoresis, risk factors — may present as fatigue alone in elderly or women | Chest pain, hemodynamic instability |
| Pulmonary embolism | Dyspnea, pleuritic pain, leg swelling, immobility, malignancy | Hypoxia, tachycardia, syncope | |
| Acute adrenal insufficiency (crisis) | Recent steroid withdrawal, hypotension, abdominal pain, vomiting | Shock, altered consciousness | |
| Acute hepatitis | Jaundice, right upper quadrant pain, dark urine, risk factors | Coagulopathy, encephalopathy |
Chronic Fatigue (Duration: Greater than 6 months)
Step-by-Step Approach to Chronic Fatigue:
- Step 1: Rule out obvious causes — Is the patient taking sedating medications? Are they sleeping adequately? Is there a clear psychiatric diagnosis?
- Step 2: Screen for the “Big Five” — Depression/anxiety, sleep disorders, thyroid disease, anemia, diabetes
- Step 3: Consider organ-specific disease — Heart failure, chronic kidney disease, liver disease, chronic infection, malignancy
- Step 4: Evaluate for less common causes if initial workup is negative — Autoimmune disease, adrenal insufficiency, vitamin deficiencies
- Step 5: Consider myalgic encephalomyelitis/chronic fatigue syndrome if criteria are met and other causes excluded
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Major depressive disorder | 20-30% | Low mood, anhedonia, guilt, sleep disturbance, appetite change, worthlessness; PHQ-9 ≥10 |
| Generalized anxiety disorder | 10-15% | Excessive worry, restlessness, muscle tension, poor concentration; GAD-7 ≥10 | |
| Sleep disorders (obstructive sleep apnea, insomnia) | 15-20% | Snoring, witnessed apneas, unrefreshing sleep, excessive daytime sleepiness; STOP-BANG ≥3 | |
| Medication-induced fatigue | 10-15% | Temporal relationship to medication; beta-blockers, antihistamines, sedatives, opioids, antidepressants | |
| Hypothyroidism | 5-10% | Cold intolerance, weight gain, constipation, dry skin, bradycardia; elevated TSH | |
| Iron deficiency anemia | 5-10% | Pallor, exertional dyspnea, pica, heavy menses, dietary deficiency; low hemoglobin, low ferritin | |
| Diabetes mellitus | 5-8% | Polyuria, polydipsia, weight change, risk factors; elevated glucose or HbA1c | |
| LESS COMMON | Heart failure | 3-5% | Exertional dyspnea, orthopnea, peripheral edema, elevated jugular venous pressure, S3 |
| Chronic kidney disease | 2-4% | Nocturia, pruritus, anorexia, nausea; elevated creatinine, low eGFR | |
| Chronic liver disease | 2-3% | Jaundice, ascites, spider angiomata, alcohol history, hepatitis risk factors | |
| Chronic obstructive pulmonary disease | 2-4% | Dyspnea, chronic cough, smoking history, barrel chest, prolonged expiration | |
| Vitamin B12 deficiency | 2-3% | Glossitis, peripheral neuropathy, cognitive changes, vegetarian diet, metformin use, elderly | |
| Myalgic encephalomyelitis/chronic fatigue syndrome | 1-3% | Post-exertional malaise (cardinal feature), unrefreshing sleep, cognitive dysfunction; diagnosis of exclusion | |
| Fibromyalgia | 2-4% | Widespread pain, tender points, sleep disturbance, cognitive symptoms, often comorbid with depression | |
| UNCOMMON BUT SERIOUS | Malignancy (solid tumor or hematologic) | 1-3% | Weight loss, night sweats, lymphadenopathy, new masses, unexplained bleeding |
| Adrenal insufficiency | <1% | Hyperpigmentation, salt craving, orthostatic hypotension, weight loss, nausea | |
| Chronic infection (tuberculosis, HIV, endocarditis) | 1-2% | Fever, night sweats, weight loss, risk factors, travel history | |
| Autoimmune disease (lupus, rheumatoid arthritis, Sjögren syndrome) | 1-2% | Joint pain, rash, dry eyes/mouth, Raynaud phenomenon, positive autoantibodies | |
| Multiple sclerosis | <1% | Neurological symptoms (visual, sensory, motor), relapsing-remitting course, young adult | |
| Hypercalcemia | <1% | Confusion, constipation, polyuria, bone pain, abdominal pain, history of malignancy |
Etiological Approach
Psychiatric/Psychological
Major depressive disorder
Generalized anxiety disorder
Somatization disorder
Burnout syndrome
Post-traumatic stress disorder
Endocrine/Metabolic
Hypothyroidism
Diabetes mellitus
Adrenal insufficiency
Hypercalcemia
Hypogonadism
Vitamin deficiencies (B12, D, iron)
Cardiopulmonary
Heart failure
Chronic obstructive pulmonary disease
Pulmonary hypertension
Obstructive sleep apnea
Anemia (all causes)
Infectious/Inflammatory/Neoplastic
Chronic infection (HIV, tuberculosis, hepatitis)
Malignancy
Autoimmune disease
Chronic kidney disease
Chronic liver disease
Drug-Induced Fatigue
| Drug or Drug Class | Mechanism | Characteristics | Time to Resolution After Stopping |
|---|---|---|---|
| Beta-blockers | Reduced cardiac output, central nervous system effects, blocked exercise response | Exertional fatigue, reduced exercise tolerance, may worsen with activity | Days to 1-2 weeks |
| Antihistamines (first-generation) | Central H1 receptor blockade, anticholinergic effects | Sedation, cognitive slowing, dry mouth; worse with diphenhydramine, hydroxyzine | 24-48 hours |
| Benzodiazepines | GABA-A receptor potentiation, central nervous system depression | Daytime sedation, cognitive impairment, tolerance may develop | Days to weeks (depending on half-life) |
| Opioids | Central nervous system depression, hypogonadism with chronic use | Sedation, cognitive impairment, secondary hypogonadism with chronic use | Days to weeks; hypogonadism may persist |
| Antidepressants (especially tricyclics, mirtazapine) | Histamine and alpha-1 blockade, muscarinic antagonism | Sedation, weight gain; may improve over time with some agents | 1-2 weeks |
| Antipsychotics | Dopamine blockade, histamine antagonism, metabolic effects | Sedation, metabolic syndrome, extrapyramidal symptoms | Days to weeks |
| Anticonvulsants | Central nervous system depression, various mechanisms | Sedation, cognitive slowing; varies by agent (worst with phenobarbital, carbamazepine) | Days to 2 weeks |
| Statins | Coenzyme Q10 depletion, mitochondrial dysfunction, myopathy | Muscle fatigue, weakness, myalgias; may develop after prolonged use | Weeks to months |
| Proton pump inhibitors (long-term) | Vitamin B12 malabsorption, magnesium deficiency | Gradual onset, associated with neuropathy, muscle cramps | Months (requires B12/magnesium repletion) |
| Diuretics | Electrolyte disturbances (hypokalemia, hyponatremia, hypomagnesemia), dehydration | Weakness, muscle cramps, lightheadedness | Days (with electrolyte correction) |
| Antihypertensives (centrally acting) | Central alpha-2 agonism (clonidine, methyldopa) | Sedation, dry mouth, depression | Days to 1 week |
| Interferon therapy | Pro-inflammatory cytokine activation | Profound fatigue, depression, flu-like symptoms | Weeks to months after discontinuation |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Fatigue worse in morning, improves through day | Depression, sleep disorder | PHQ-9, sleep history, consider sleep study |
| Fatigue worsens disproportionately after exertion | Myalgic encephalomyelitis/chronic fatigue syndrome, heart failure | Detailed post-exertional malaise history, echocardiogram, BNP |
| Snoring, obesity, unrefreshing sleep | Obstructive sleep apnea | STOP-BANG score, polysomnography |
| Cold intolerance, weight gain, constipation | Hypothyroidism | TSH, free T4 |
| Pallor, exertional dyspnea, tachycardia | Anemia | Complete blood count, reticulocyte count, iron studies |
| Polyuria, polydipsia, weight change | Diabetes mellitus | Fasting glucose, HbA1c |
| Weight loss, night sweats, lymphadenopathy | Malignancy, chronic infection | Urgent evaluation: CT imaging, lymph node biopsy, infection workup |
| Hyperpigmentation, salt craving, orthostatic symptoms | Adrenal insufficiency | Morning cortisol, ACTH stimulation test |
| Exertional dyspnea, orthopnea, leg edema | Heart failure | BNP/NT-proBNP, echocardiogram, chest X-ray |
| Joint pain, rash, dry eyes/mouth | Autoimmune disease | ANA, RF, anti-CCP, ESR, CRP |
| Glossitis, paresthesias, ataxia | Vitamin B12 deficiency | Vitamin B12 level, methylmalonic acid |
| New medication within past weeks to months | Drug-induced fatigue | Medication review, trial discontinuation if safe |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Baseline Investigations for All Patients with Unexplained Fatigue
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Complete blood count | Screen for anemia, infection, hematologic malignancy | Low hemoglobin, abnormal MCV, leukocytosis/leukopenia, thrombocytopenia | Check MCV to classify anemia; review peripheral smear if abnormalities |
| Comprehensive metabolic panel | Assess kidney function, liver function, electrolytes, glucose | Elevated creatinine, abnormal liver enzymes, electrolyte disturbances, hyperglycemia | Includes fasting glucose; calculate eGFR for kidney function |
| Thyroid-stimulating hormone (TSH) | Screen for thyroid dysfunction | Elevated TSH (hypothyroidism), suppressed TSH (hyperthyroidism) | If abnormal, add free T4; consider free T3 if hyperthyroidism suspected |
| Ferritin | Assess iron stores | Low ferritin (<30 ng/mL) indicates iron deficiency | May be falsely normal in inflammation (acute phase reactant); check with CRP |
| Erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) | Screen for inflammation, infection, malignancy | Elevated values suggest inflammatory or infectious process | Non-specific; guides further investigation rather than diagnosis |
| Urinalysis | Screen for kidney disease, diabetes, infection | Proteinuria, glucosuria, hematuria, pyuria | Simple and inexpensive; can reveal occult disease |
The “Minimum Fatigue Panel”
For any patient with unexplained fatigue lasting more than 2-4 weeks, the minimum initial workup should include:
- Complete blood count with differential
- Comprehensive metabolic panel (including glucose, kidney function, liver enzymes)
- Thyroid-stimulating hormone
- Ferritin (with or without iron studies)
- Inflammatory marker (ESR or CRP)
- Urinalysis
This panel screens for the majority of common organic causes at reasonable cost.
Second-Tier Investigations (Based on Clinical Suspicion or Abnormal Baseline Tests)
| Investigation | When to Order | What to Look For |
|---|---|---|
| Hemoglobin A1c | If glucose borderline, risk factors for diabetes, or symptoms suggestive | ≥6.5% diagnostic of diabetes; 5.7-6.4% indicates prediabetes |
| Iron studies (serum iron, TIBC, transferrin saturation) | Low ferritin, microcytic anemia, suspected iron deficiency despite normal ferritin | Low serum iron, high TIBC, low saturation (<20%) in iron deficiency |
| Vitamin B12 level | Macrocytic anemia, neurological symptoms, elderly, vegetarian/vegan, metformin use, PPI use | Low B12 (<200 pg/mL); borderline values (200-400) may need methylmalonic acid |
| Folate level | Macrocytic anemia, alcoholism, malnutrition, malabsorption | Low folate; often checked with B12 |
| Vitamin D level (25-hydroxyvitamin D) | Musculoskeletal symptoms, limited sun exposure, dark skin, obesity, malabsorption | <20 ng/mL indicates deficiency; 20-30 ng/mL indicates insufficiency |
| Free T4 | Abnormal TSH | Low in primary hypothyroidism; high in hyperthyroidism |
| BNP or NT-proBNP | Dyspnea, edema, suspected heart failure | BNP >100 pg/mL or NT-proBNP >300 pg/mL suggests heart failure (age-adjusted cutoffs) |
| Chest X-ray | Respiratory symptoms, smoking history, suspected cardiopulmonary disease | Cardiomegaly, pulmonary infiltrates, masses, pleural effusions |
Targeted Investigations by Suspected Etiology
If Suspecting Depression or Anxiety
Clinical Assessment
- PHQ-9: Score ≥10 indicates moderate depression; ≥15 moderately severe; ≥20 severe
- GAD-7: Score ≥10 indicates moderate anxiety
- Columbia Suicide Severity Rating Scale: If suicidal ideation present
Laboratory Considerations
- Ensure baseline labs are normal to rule out organic causes
- Consider TSH (hypothyroidism can mimic depression)
- Consider vitamin B12 (deficiency can cause psychiatric symptoms)
If Suspecting Sleep Disorder
Screening Tools
- STOP-BANG questionnaire: Score ≥3 indicates intermediate-to-high risk for obstructive sleep apnea
- Epworth Sleepiness Scale: Score >10 indicates excessive daytime sleepiness
- Insomnia Severity Index: Quantifies insomnia severity
Diagnostic Testing
- Polysomnography: Gold standard for obstructive sleep apnea; Apnea-Hypopnea Index ≥5 with symptoms is diagnostic
- Home sleep apnea testing: Alternative for uncomplicated cases with high pretest probability
- Actigraphy: Assess sleep-wake patterns over days to weeks
If Suspecting Anemia
Classification by MCV
- Microcytic (MCV <80 fL): Iron studies, consider thalassemia screen, lead level if indicated
- Normocytic (MCV 80-100 fL): Reticulocyte count, peripheral smear, consider hemolysis workup (LDH, haptoglobin, bilirubin)
- Macrocytic (MCV >100 fL): Vitamin B12, folate, reticulocyte count, consider liver function tests, TSH
Further Workup
- Reticulocyte count: Elevated in hemolysis or acute blood loss; low in production problems
- Peripheral blood smear: Morphology guides diagnosis
- Gastrointestinal evaluation: If iron deficiency in men or postmenopausal women (rule out occult bleeding)
If Suspecting Adrenal Insufficiency
First-Line Tests
- Morning cortisol (8-9 AM): <3 μg/dL highly suggestive; >15-18 μg/dL generally excludes; intermediate values need further testing
- ACTH stimulation test: Gold standard; cortisol should rise to >18-20 μg/dL at 30 or 60 minutes
Additional Tests
- ACTH level: Elevated in primary adrenal insufficiency; low/normal in secondary
- Electrolytes: Hyponatremia, hyperkalemia (primary)
- Adrenal antibodies: If primary adrenal insufficiency confirmed (autoimmune etiology)
If Suspecting Malignancy
Initial Evaluation
- Complete blood count: Cytopenias, leukocytosis, abnormal cells
- Lactate dehydrogenase: Elevated in lymphoma and many malignancies
- Peripheral blood smear: Abnormal cells, leukoerythroblastic picture
- Chest X-ray: Masses, lymphadenopathy, effusions
Further Investigation
- CT chest/abdomen/pelvis: If clinical suspicion high, weight loss, lymphadenopathy
- Age-appropriate cancer screening: Ensure up to date
- Serum protein electrophoresis: If suspected myeloma
- Tissue biopsy: If mass or lymphadenopathy identified
If Suspecting Autoimmune Disease
Screening Tests
- Antinuclear antibody (ANA): Sensitive but not specific; positive in many autoimmune conditions
- ESR and CRP: Markers of inflammation
- Complete blood count: Cytopenias common in lupus
Specific Antibodies (if ANA positive or high suspicion)
- Anti-dsDNA, anti-Smith: Specific for systemic lupus erythematosus
- Rheumatoid factor, anti-CCP: Rheumatoid arthritis
- Anti-SSA/SSB: Sjögren syndrome
- Complement levels (C3, C4): Low in active lupus
Empiric Treatment Trials as Diagnostic Tools
Sequential Empiric Therapy Approach
When diagnosis remains unclear after initial workup, empiric treatment trials may serve as diagnostic tools. Response to therapy supports the suspected diagnosis. Use this approach judiciously:
- Iron supplementation trial: If ferritin 15-50 ng/mL (low-normal), trial oral iron for 4-8 weeks — improvement suggests iron deficiency even with “normal” ferritin
- Vitamin D supplementation: If vitamin D <30 ng/mL, replace with high-dose vitamin D for 8-12 weeks — assess for improvement in fatigue and musculoskeletal symptoms
- Antidepressant trial: If depression suspected but patient uncertain about diagnosis, trial SSRI for 4-6 weeks — response supports diagnosis (though not diagnostic)
- Sleep hygiene optimization: Before ordering polysomnography, trial structured sleep hygiene for 2-4 weeks — improvement suggests behavioral insomnia
- Medication discontinuation trial: If drug-induced fatigue suspected and safe to stop, discontinue medication for 2-4 weeks — resolution confirms medication as cause
Investigation Summary by Clinical Scenario
| Clinical Scenario | Key Investigations | Consider Adding |
|---|---|---|
| Young woman with heavy menses and fatigue | CBC, ferritin, iron studies | TSH, reticulocyte count if anemia confirmed |
| Middle-aged obese patient with snoring | STOP-BANG, TSH, glucose/HbA1c | Polysomnography, lipid panel |
| Elderly patient with weight loss and fatigue | CBC, CMP, TSH, ESR/CRP, chest X-ray | CT imaging, age-appropriate cancer screening, LDH |
| Patient on multiple medications with new fatigue | Review medication list, basic labs (CBC, CMP, TSH) | Trial medication discontinuation if appropriate |
| Young patient with post-exertional worsening | Complete baseline panel, TSH, ferritin | Consider myalgic encephalomyelitis/chronic fatigue syndrome criteria if workup negative |
| Patient with joint pain, rash, and fatigue | CBC, CMP, ESR/CRP, ANA, urinalysis | Specific autoantibodies, complement levels, referral to rheumatology |
Avoid Excessive Testing
The “shotgun” approach is rarely helpful. Ordering extensive panels without clinical indication leads to false positives, unnecessary follow-up testing, patient anxiety, and healthcare costs. A targeted approach based on thorough history and examination has the highest diagnostic yield. If the baseline panel is normal and clinical suspicion for serious disease is low, it is appropriate to reassess in 4-6 weeks rather than ordering additional tests immediately.
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Fatigue with chest pain, severe dyspnea, or hemodynamic instability | EMERGENT | Emergency department evaluation; ECG, troponin, consider pulmonary embolism workup |
| Fatigue with suicidal ideation or severe depression | EMERGENT | Urgent psychiatric evaluation; ensure patient safety; do not leave patient alone |
| Fatigue with signs of adrenal crisis (hypotension, vomiting, confusion) | EMERGENT | Immediate IV fluids, IV hydrocortisone 100mg; do not wait for lab confirmation |
| Fatigue with severe anemia (hemoglobin <7 g/dL) or active bleeding | EMERGENT | Type and screen, transfusion, identify bleeding source |
| Fatigue with fever, weight loss, and lymphadenopathy | URGENT | Expedited workup within days; CBC, imaging, possible biopsy |
| Fatigue with new focal neurological deficits | URGENT | Urgent neuroimaging; consider stroke, demyelinating disease, mass lesion |
| Fatigue with significant unintentional weight loss (>5%) | URGENT | Comprehensive workup within 1-2 weeks; malignancy and chronic disease evaluation |
| Fatigue with moderate depression affecting function | URGENT | Initiate treatment within days; close follow-up; assess suicide risk |
| Chronic fatigue without red flags, stable symptoms | ROUTINE | Systematic evaluation over weeks; baseline labs, targeted workup based on findings |
| Fatigue clearly related to lifestyle factors (sleep deprivation, stress) | ROUTINE | Address modifiable factors; reassess if no improvement in 4-6 weeks |
Step 2: Classify by Duration
Acute (<1 month)
Focus on: Acute illness, recent medication changes, acute stressors, sleep disruption
Action: Targeted history and examination; basic labs only if indicated; often self-limited
Proceed to Algorithm A
Subacute (1-6 months)
Focus on: Post-viral syndrome, undiagnosed common conditions, emerging chronic disease
Action: Baseline fatigue panel; screen for depression and sleep disorders
Proceed to Algorithm B
Chronic (>6 months)
Focus on: Chronic diseases, psychiatric disorders, sleep disorders, myalgic encephalomyelitis/chronic fatigue syndrome
Action: Comprehensive evaluation; consider specialty referral if unrevealing
Proceed to Algorithm C
Step 3: Follow the Appropriate Algorithm
Algorithm A: Acute Fatigue (<1 month)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Fever, myalgias, upper respiratory symptoms, sick contacts | Acute viral infection | Supportive care; expect resolution in 1-2 weeks; red flag counseling |
| Clear sleep deprivation history (new baby, shift work, lifestyle) | Sleep deprivation | Sleep hygiene counseling; address underlying cause; reassess if persists |
| Recent major stressor, anxiety, difficulty coping | Acute stress reaction | Supportive counseling; consider short-term anxiolytic; follow-up in 2-4 weeks |
| Temporal relationship to new medication | Medication-induced fatigue | Review necessity of medication; consider dose reduction or alternative; reassess |
| Young adult with severe fatigue, pharyngitis, lymphadenopathy | Infectious mononucleosis | Heterophile antibody test; supportive care; avoid contact sports if splenomegaly |
| Pallor, heavy menses, known bleeding source | Acute anemia from blood loss | Urgent CBC; assess hemodynamic stability; identify and treat bleeding source |
Algorithm B: Subacute Fatigue (1-6 months)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Fatigue following documented viral illness, no other findings | Post-viral fatigue syndrome | Reassurance; graded activity; baseline labs; monitor for evolution to chronic fatigue syndrome |
| Low mood, anhedonia, sleep/appetite changes, PHQ-9 ≥10 | Major depressive disorder | Initiate antidepressant and/or psychotherapy; close follow-up; assess response at 4-6 weeks |
| Excessive worry, restlessness, poor concentration, GAD-7 ≥10 | Generalized anxiety disorder | Consider SSRI/SNRI or cognitive behavioral therapy; address sleep if affected |
| Snoring, obesity, unrefreshing sleep, daytime sleepiness | Obstructive sleep apnea | Polysomnography; if positive, initiate CPAP therapy |
| Cold intolerance, weight gain, constipation, elevated TSH | Hypothyroidism | Initiate levothyroxine; recheck TSH in 6-8 weeks; titrate to goal |
| Pallor, low hemoglobin, low ferritin | Iron deficiency anemia | Oral iron supplementation; investigate cause; recheck in 4-8 weeks |
| Polyuria, polydipsia, elevated glucose | New-onset diabetes mellitus | Confirm diagnosis; initiate appropriate therapy; diabetes education |
Algorithm C: Chronic Fatigue (>6 months)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Baseline labs normal, PHQ-9 ≥10, no other explanation | Depression as primary cause | Optimize antidepressant therapy; consider augmentation; psychotherapy referral |
| Baseline labs normal, clear sleep disorder on polysomnography | Sleep disorder | CPAP for sleep apnea; cognitive behavioral therapy for insomnia; reassess response |
| Exertional dyspnea, elevated BNP, abnormal echocardiogram | Heart failure | Cardiology referral; guideline-directed medical therapy; cardiac rehabilitation |
| Elevated creatinine, low eGFR, anemia | Chronic kidney disease | Nephrology referral; address anemia with erythropoiesis-stimulating agents; manage complications |
| Weight loss, lymphadenopathy, abnormal imaging | Malignancy | Urgent oncology referral; tissue diagnosis; staging |
| Post-exertional malaise, unrefreshing sleep, cognitive dysfunction, all workup negative | Myalgic encephalomyelitis/chronic fatigue syndrome | Apply diagnostic criteria; activity pacing; treat comorbidities; avoid graded exercise |
| Widespread pain, tender points, sleep disturbance, workup negative | Fibromyalgia | Multimodal approach: exercise, sleep optimization, duloxetine/pregabalin, cognitive behavioral therapy |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| All baseline labs are normal | Reassess history for psychiatric, sleep, or lifestyle causes | Consider PHQ-9/GAD-7 if not done; sleep study if indicated; reassess in 4-6 weeks |
| Patient insists “something is wrong” despite normal workup | Validate concerns; review for missed diagnoses; consider second-tier tests | Consider specialist referral; evaluate for somatization; maintain therapeutic relationship |
| Fatigue persists despite treating identified cause | Verify treatment adequacy and adherence; reassess diagnosis | Consider multiple overlapping causes; expand workup; specialty referral |
| Patient on multiple medications with new fatigue | Perform comprehensive medication review | Prioritize discontinuation of most likely offenders; reassess in 2-4 weeks |
| Borderline-low ferritin (15-50 ng/mL) with normal hemoglobin | Consider iron deficiency without anemia as cause | Trial oral iron for 8-12 weeks; reassess symptoms and ferritin |
| TSH slightly elevated (5-10 mIU/L) with normal free T4 | Subclinical hypothyroidism; significance uncertain | Recheck in 2-3 months; consider treatment trial if symptoms correlate; check TPO antibodies |
| Patient meets criteria for myalgic encephalomyelitis/chronic fatigue syndrome | Confirm diagnosis; educate patient; validate experience | Activity pacing; treat comorbidities; avoid pushing through fatigue; long-term supportive care |
| Strong suspicion for depression but patient reluctant to accept diagnosis | Explore patient’s understanding and concerns; destigmatize | Frame treatment as trial; offer psychotherapy as alternative; maintain follow-up |
Troubleshooting Refractory Fatigue
Ask These Questions When Fatigue Persists
- Was the initial diagnosis correct? — Revisit the history and examination; consider alternative diagnoses
- Is treatment adequate? — Check doses, duration, and therapeutic levels if applicable
- Is the patient adherent to treatment? — Medication adherence, CPAP use, lifestyle modifications
- Are there multiple overlapping causes? — Depression plus sleep apnea plus hypothyroidism is common
- Is there an undiagnosed comorbidity? — New symptoms may have emerged; repeat focused workup
- Are medications contributing? — New medications added since initial evaluation?
- Have psychosocial factors been adequately addressed? — Ongoing stressors, relationship issues, work problems
- Is specialist referral indicated? — Consider sleep medicine, psychiatry, rheumatology, or internal medicine subspecialties
When to Refer
| Specialty | Indications for Referral |
|---|---|
| Sleep Medicine | Suspected sleep apnea requiring polysomnography; narcolepsy; complex insomnia; restless legs syndrome |
| Psychiatry | Treatment-resistant depression; suicidal ideation; complex psychiatric comorbidity; diagnostic uncertainty |
| Endocrinology | Suspected adrenal insufficiency; complex thyroid disease; pituitary disorders; unexplained hypercalcemia |
| Hematology | Unexplained cytopenias; suspected hematologic malignancy; complex anemia workup |
| Rheumatology | Suspected autoimmune disease; positive autoantibodies with symptoms; fibromyalgia refractory to treatment |
| Cardiology | Suspected heart failure; unexplained dyspnea; abnormal echocardiogram or BNP |
| Infectious Disease | Suspected chronic infection (HIV, tuberculosis, endocarditis); fever of unknown origin |
| Oncology | Suspected malignancy; unexplained weight loss with concerning features |
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
The “Big Five” dominate: Depression, anxiety, sleep disorders, thyroid disease, and anemia account for the majority of identifiable causes. Screen systematically for these before expanding the workup.
Distinguish fatigue from sleepiness and weakness: These have different differential diagnoses. True fatigue is not relieved by rest; sleepiness is relieved by sleep; weakness is objective motor impairment.
Multiple causes are common: Up to 40% of patients with chronic fatigue have more than one contributing factor. Finding one diagnosis does not mean the workup is complete.
Medications are frequently overlooked: Always perform a thorough medication review. Beta-blockers, antihistamines, and sedatives are common culprits that may have been tolerated for years before causing problems.
Iron deficiency can cause fatigue before anemia develops: A ferritin below 30-50 ng/mL may cause symptoms even with normal hemoglobin. Consider an iron trial in symptomatic patients with low-normal ferritin.
Post-exertional malaise is the hallmark of myalgic encephalomyelitis/chronic fatigue syndrome: If activity makes fatigue disproportionately worse for days afterward, think of this diagnosis — and avoid recommending graded exercise, which can cause harm.
Depression and fatigue are bidirectional: Chronic fatigue can cause depression, and depression causes fatigue. Treat both simultaneously when present together.
Normal examination is the rule, not the exception: Many common causes of fatigue (depression, early thyroid disease, sleep disorders, medication effects) have completely normal physical examinations. Do not be falsely reassured.
Critical Pitfalls to Avoid
Dismissing fatigue as “just stress” without evaluation: While stress and lifestyle factors are common causes, dismissing the complaint without systematic evaluation misses organic disease in a significant minority of patients.
Ordering extensive testing without clinical indication: The “shotgun” approach leads to false positives, unnecessary follow-up, patient anxiety, and healthcare costs. A targeted approach based on history and examination is more effective.
Missing obstructive sleep apnea in non-obese patients: While obesity is a risk factor, sleep apnea occurs in thin patients too. Ask about snoring and witnessed apneas regardless of body habitus.
Assuming depression is primary without ruling out organic causes: Depression can be secondary to hypothyroidism, anemia, malignancy, and many other conditions. Baseline labs should precede or accompany psychiatric diagnosis.
Stopping the workup after finding one diagnosis: Multiple contributing factors are common. If the patient does not improve adequately with treatment of one cause, continue to evaluate for others.
Recommending graded exercise for suspected myalgic encephalomyelitis/chronic fatigue syndrome: This can cause significant harm. Post-exertional malaise means the patient gets worse, not better, with activity. Activity pacing is the appropriate approach.
Ignoring the medication list: Drug-induced fatigue is one of the most treatable causes. A medication that was tolerated for years can become problematic with age, new interactions, or changing physiology.
Failing to address weight loss, night sweats, or lymphadenopathy urgently: These red flags require expedited evaluation for malignancy and serious infection. Do not adopt a “wait and see” approach.
Key Takeaways
- Fatigue is one of the most common and challenging presenting complaints, accounting for 5-10% of primary care visits with an identifiable organic cause in only 50-60% of cases.
- Always distinguish fatigue (not relieved by rest) from sleepiness (relieved by sleep) and weakness (objective motor deficit) — they have different differential diagnoses.
- Duration matters: acute fatigue (<1 month) is often self-limited; subacute (1-6 months) warrants systematic evaluation; chronic (>6 months) requires comprehensive workup.
- The “Big Five” — depression/anxiety, sleep disorders, thyroid disease, anemia, and diabetes — account for the majority of identifiable causes and should be screened for systematically.
- A “Minimum Fatigue Panel” (CBC, CMP, TSH, ferritin, inflammatory marker, urinalysis) is appropriate for all patients with unexplained fatigue lasting more than 2-4 weeks.
- Multiple contributing causes are present in up to 40% of patients — finding one diagnosis does not mean the workup is complete.
- Medication review is essential. Drug-induced fatigue is common and highly treatable if recognized.
- Normal physical examination is common in many causes of fatigue (depression, early thyroid disease, sleep apnea, medication effects) and does not exclude significant pathology.
- Red flags (weight loss, night sweats, fever, lymphadenopathy, neurological deficits, suicidal ideation) require urgent evaluation — do not adopt a “wait and see” approach.
- Post-exertional malaise (fatigue worsens disproportionately after activity) is the hallmark of myalgic encephalomyelitis/chronic fatigue syndrome. Graded exercise can cause harm in these patients.
Quick Reference Algorithm
Systematic Approach to Fatigue:
- Assess urgency: Screen for red flags requiring emergent or urgent evaluation (chest pain, severe dyspnea, suicidal ideation, weight loss, fever, lymphadenopathy).
- Clarify the symptom: Distinguish true fatigue from sleepiness and weakness; characterize duration, pattern, and impact.
- Take a comprehensive history: Use the “TIRED” mnemonic — Timeline, Impact, Rest/Recovery, Emotional state, Drugs/Diet/Disease.
- Screen for the Big Five: Depression (PHQ-9), anxiety (GAD-7), sleep disorders (STOP-BANG, Epworth), thyroid disease (TSH), anemia (CBC, ferritin).
- Perform a focused physical examination: Vital signs (including orthostatics), thyroid, lymph nodes, cardiopulmonary, abdominal, and neurological examination.
- Order baseline investigations: CBC, CMP, TSH, ferritin, ESR or CRP, urinalysis for all patients with unexplained fatigue lasting more than 2-4 weeks.
- Treat identified causes: Address each contributing factor; reassess response in 4-8 weeks.
- If initial workup negative: Consider second-tier tests based on clinical suspicion; evaluate for multiple overlapping causes; consider specialist referral.
- If chronic and unexplained: Evaluate for myalgic encephalomyelitis/chronic fatigue syndrome criteria; provide supportive care; avoid graded exercise if post-exertional malaise present.
- Maintain follow-up: Fatigue often requires ongoing management; reassess periodically for new findings or evolving diagnoses.